INTERFERON BETA-1A — all Canadian products
11 DINs
6 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is INTERFERON BETA-1A, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02269201 | AVONEX | BIOGEN CANADA INC | Solution | Intramuscular | INTERFERON BETA-1A 30 MCG | Marketed | |
| 02267594 | AVONEX | BIOGEN CANADA INC | Powder For Solution | Intramuscular | INTERFERON BETA-1A 60 MCG | Approved | |
| 02237319 | REBIF | EMD SERONO, A DIVISION OF EMD INC., CANADA | Solution | Subcutaneous | INTERFERON BETA-1A 22 MCG | Marketed | |
| 02237320 | REBIF | EMD SERONO, A DIVISION OF EMD INC., CANADA | Solution | Subcutaneous | INTERFERON BETA-1A 44 MCG | Marketed | |
| 02318261 | REBIF | EMD SERONO, A DIVISION OF EMD INC., CANADA | Solution | Subcutaneous | INTERFERON BETA-1A 132 MCG | Marketed | |
| 02318253 | REBIF | EMD SERONO, A DIVISION OF EMD INC., CANADA | Solution | Subcutaneous | INTERFERON BETA-1A 66 MCG | Marketed | |
| 02237770 | AVONEX | BIOGEN CANADA INC | Powder For Solution | Intramuscular | INTERFERON BETA-1A 30 MCG; WATER 1.1 ML | Cancelled Post Market | |
| 02281708 | REBIF | EMD SERONO, A DIVISION OF EMD INC., CANADA | Powder For Solution; Kit; Liquid | Subcutaneous | INTERFERON BETA-1A 8.8 MCG; INTERFERON BETA-1A 22 MCG | Cancelled Post Market | |
| 02237317 | REBIF | EMD SERONO, A DIVISION OF EMD INC., CANADA | Liquid; Powder; Kit | Subcutaneous; Intralesional | INTERFERON BETA-1A 11 MCG; SODIUM CHLORIDE 2 ML | Cancelled Post Market | |
| 02318288 | REBIF | EMD SERONO, A DIVISION OF EMD INC., CANADA | Solution | Subcutaneous | INTERFERON BETA-1A 132 MCG | Cancelled Pre Market | |
| 02277492 | REBIF | EMD SERONO, A DIVISION OF EMD INC., CANADA | Solution | Subcutaneous | INTERFERON BETA-1A 8.8 MCG | Cancelled Post Market |
Browse other molecules: